Subcommittee on Procedures Review, Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH), 54775-54776 [2011-22501]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 171 / Friday, September 2, 2011 / Notices
Organizations that Serve Minority
Communities, REACH MNO. These
applications have been previously
received and competed in response to
CDC Funding Opportunity CDC–RFA–
DP09–905. It is the intent of CDC to
provide continuation funding to three
(3) previously received and reviewed
applications with Patient Protection
Affordable Care Act (PPACA), Section
4002, appropriations.
Recipient Reporting Requirements
Under PPACA
Recipients funded with PPACA
appropriations will be required to report
project status on an annual basis.
Specific reporting requirements will be
detailed in the Terms and Conditions of
the Notice of Cooperative Agreement
Award.
CFDA Number 93.541 is the PPACA
specific CFDA number for this
initiative. It will replace CFDA Number
93.283 published in the above
referenced REACH MNO Funding
Opportunity Announcement (FOA).
erowe on DSK5CLS3C1PROD with NOTICES
Award Information
Approximate Current Fiscal Year
Funding: $750,000.
Approximate Number of Awards: 3.
Approximate Average Awards:
$250,000.
Fiscal Year Funds: 2011.
Anticipated Award Date: September
30, 2011.
Budget Period: 12 months.
Project Period: 12 months.
Application Selection Process:
Grantees have been selected based on
methodology published in the REACH
MNO CDC–RFA–DP09–905 FOA.
Applications were funded in order by
score and rank determined by
previously held review panel.
CDC will add the following Authority
to that which is reflected in the
published Funding Opportunity:
Section 4002 of the Patient Protection
and Affordability Care Act (Pub. L. 111–
148).
DATES: The effective date for this action
is September 2, 2011 and remains in
effect until the expiration of the one (1)
year project period of the PPACA
funded applications.
FOR FURTHER INFORMATION CONTACT:
Elmira Benson, Deputy Director,
Procurement and Grants Office, Centers
for Disease Control and Prevention,
2920 Brandywine Road, Atlanta, GA
30341, telephone: (770) 488–2802,
e-mail: EBenson@cdc.gov.
SUPPLEMENTARY INFORMATION: On March
23, 2010, the President signed into law
the Patient Protection and Affordable
Care Act (PPACA). PPACA is designed
VerDate Mar<15>2010
15:37 Sep 01, 2011
Jkt 223001
to improve and expand the scope of
health care coverage for Americans. Cost
savings through disease prevention is an
important element of this legislation
and PPACA has established a
Prevention and Public Health Fund
(PPHF) for this purpose. Specifically,
the legislation states in Section 4002
that the PPHF is to ‘‘provide for
expanded and sustained national
investment in prevention and public
health programs to improve health and
help restrain the rate of growth in
private and public sector health care
costs’’. PPACA and the Prevention and
Public Health Fund make improving
public health a priority with
investments to improve public health.
The PPHF states that the Secretary
shall transfer amounts in the Fund to
accounts within the Department of
Health and Human Services to increase
funding, over the fiscal year 2008 level,
for programs authorized by the public
Health Services Act, for prevention,
wellness and public health activities
including prevention research and
health screenings, such as the
Community Transformation Grant
Program, the Education and Outreach
Campaign for Preventative Benefits, and
Immunization Programs.
REACH MNO and PPACA legislation
affords an important opportunity to
advance public health across the
lifespan and to reduce health disparities
by supporting an intensive community
approach to chronic disease prevention
and control. Therefore, awarding
cooperative agreements with PPACA
funds under PPHF to existing grantees
to carry out REACH objectives is
consistent with the purpose of PPHF, as
stated above, to provide for the
expanded and sustained national
investment in prevention and public
health programs. Further, the Secretary
allocated funds to CDC, pursuant to the
PPHF, for the types of activities that the
REACH initiatives are designed to carry
out.
Therefore, the REACH program
activities CDC proposes to fund with
PPACA appropriations are authorized
by the amendment to the Public Health
Services Act which authorized the
Prevention and Wellness Program as
embodied in CDC–RFA–DP09–905.
Dated: August 22, 2011.
Tanja Popovic,
Deputy Associate Director for Science,
Centers for Disease Control and Prevention.
[FR Doc. 2011–22499 Filed 9–1–11; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
54775
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Subcommittee on Procedures Review,
Advisory Board on Radiation and
Worker Health (ABRWH), National
Institute for Occupational Safety and
Health (NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting for the
aforementioned subcommittee:
Time and Date: 9 a.m.–5 p.m.,
September 19, 2011.
Place: Cincinnati Airport Marriott,
2395 Progress Drive, Hebron, Kentucky
41018, Telephone: (859) 334–4611, Fax:
(859) 334–4619.
Status: Open to the public. In the
event an individual wishes to provide
comments, written comments must be
submitted prior to the meeting. To
access by conference call dial the
following information: (866) 659–0537,
Participant Pass Code 9933701.
Background: The ABRWH was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
compensation program. Key functions of
the ABRWH include providing advice
on the development of probability of
causation guidelines that have been
promulgated by the Department of
Health and Human Services (HHS) as a
final rule; advice on methods of dose
reconstruction which have also been
promulgated by HHS as a final rule;
advice on the scientific validity and
quality of dose estimation and
reconstruction efforts being performed
for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special
Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the ABRWH to
HHS, which subsequently delegated this
authority to CDC. NIOSH implements
this responsibility for CDC. The charter
was issued on August 3, 2001, renewed
at appropriate intervals, and will expire
on August 3, 2013.
Purpose: The ABRWH is charged with
(a) providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b)
providing advice to the Secretary, HHS,
on the scientific validity and quality of
E:\FR\FM\02SEN1.SGM
02SEN1
erowe on DSK5CLS3C1PROD with NOTICES
54776
Federal Register / Vol. 76, No. 171 / Friday, September 2, 2011 / Notices
dose reconstruction efforts performed
for this program; and (c) upon request
by the Secretary, HHS, advising the
Secretary on whether there is a class of
employees at any Department of Energy
facility who were exposed to radiation
but for whom it is not feasible to
estimate their radiation dose, and on
whether there is a reasonable likelihood
that such radiation doses may have
endangered the health of members of
this class. The Subcommittee on
Procedures Review was established to
aid the ABRWH in carrying out its duty
to advise the Secretary, HHS, on dose
reconstructions. The Subcommittee on
Procedures Review is responsible for
overseeing, tracking, and participating
in the reviews of all procedures used in
the dose reconstruction process by the
NIOSH Division of Compensation
Analysis and Support (DCAS) and its
dose reconstruction contractor.
Matters To Be Discussed: The agenda
for the Subcommittee meeting includes
discussion of the following ORAU and
OCAS procedures: ORAUT–RPRT–0044
(‘‘Analysis of Bioassay Data with a
Significant Fraction of Less-Than
Results’’), OCAS TIB–0013 (‘‘Special
External Dose Reconstruction
Considerations for Mallinckrodt
Workers’’), OTIB–0019 (‘‘Analysis of
Coworker Bioassay Data for Internal
Dose Assignment’’), OTIB–0021
(External Coworker Dosimetry Data for
the X–10 Site), OTIB–0029 (‘‘Internal
Dosimetry Coworker Data for Y–12’’),
OTIB–0047 (‘‘External Radiation
Monitoring at the Y–12 Facility During
the 1948–1949 Period’’), OTIB–0049
(‘‘Estimating Doses for Plutonium
Strongly Retained in the Lung’’), OTIB–
0052 (‘‘Parameters to Consider When
Processing Claims for Construction
Trade Workers’’), OTIB–0054 (‘‘Fission
and Activation Product Assignment for
Internal Dose-Related Gross Beta and
Gross Gamma Analyses’’), and OTIB–
0070 (‘‘Dose Reconstruction During
Residual Radioactivity Periods at
Atomic Weapons Employer Facilities’’);
and a continuation of the commentresolution process for other dose
reconstruction procedures under review
by the Subcommittee.
The agenda is subject to change as
priorities dictate.
This meeting is open to the public. In
the event an individual wishes to
provide comments, written comments
must be submitted prior to the meeting.
Any written comments received will be
provided at the meeting and should be
submitted to the contact person below
in advance of the meeting.
Contact Person for More Information:
Theodore Katz, Executive Secretary,
NIOSH, CDC, 1600 Clifton Road,
VerDate Mar<15>2010
15:37 Sep 01, 2011
Jkt 223001
Mailstop E–20, Atlanta, Georgia 30333,
Telephone: (513) 533–6800, Toll Free: 1
(800) CDC–INFO, E-mail dcas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Dated: August 29, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2011–22501 Filed 9–1–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10390 and
10409]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: New collection; Title of
Information Collection: Hospice
Voluntary Quality Data Reporting
Program; Use: Section 1814(i)(5) of the
Social Security Act (Act) added by
section 3004 of Patient Protection and
Affordable Care Act, Public Law 111–
148, enacted on March 23, 2010
(Affordable Care Act), authorizes the
AGENCY:
PO 00000
Frm 00047
Fmt 4703
Sfmt 4703
Secretary to establish a quality reporting
program for hospices. Section
1814(i)(5)(A)(i) of the Act requires that
the Secretary, beginning with FY 2014,
reduce the market basket update by 2
percentage points for any hospice that
does not comply with the quality data
submission requirements with respect to
that fiscal year.
To meet the quality reporting
requirements for hospices, as set forth in
the proposed Hospice Wage Index for
Fiscal Year 2012 rule, we propose that
there shall be a voluntary hospice
quality reporting cycle which will
consist of data collection cycle
beginning on October 1, 2011 and
continuing through December 31, 2011.
This data shall be reported to CMS by
no later than January 31, 2012. There
shall be a mandatory hospice quality
reporting cycle which will consist of
data collected from October 1, 2012
through December 31, 2012. This data
shall be reported to CMS by no later
than April 1, 2013. Thereafter, it is
proposed that all subsequent hospice
quality reporting cycles will be based on
the calendar-year basis(that is, January
1, 2013 through December 31, 2013 for
determination of the Hospice market
basket increase factor for each Hospice
in FY 2015, etc.).
We are requesting an initial approval
of a data collection instrument entitled
‘‘Quality Data Submission Form’’ that
hospice providers will use to submit
quality measures data to CMS during
the proposed voluntary reporting period
of 10/01/2011 through 12/31/2011. This
form shall be used by hospices to report
quality data pertaining to one structural
measure, which is entitled: Participation
in a Quality Assessment and
Performance Improvement (QAPI)
Program that Includes at Least Three
Quality Indicators Related to Patient
Care. Form Number: CMS–10390 (OMB
0938–New); Frequency: Occasionally;
Affected Public: Private Sector: Business
or other for-profit and not-for-profit
institutions; Number of Respondents:
3,531; Total Annual Responses: 3,531;
Total Annual Hours: 883. (For policy
questions regarding this collection
contact Robin Dowell at 410–786–0060.
For all other issues call 410–786–1326.)
2. Type of Information Collection
Request: New collection; Title of
Information Collection: Long Term Care
Hospital (LCTH) Quality Reporting
Program—Pressure Ulcer Measure Data
Set; Use: Section 3004 of the Affordable
Care Act authorizes the establishment of
a new quality reporting program for
Long Term Care Hospitals (LTCHs).
LTCHs that fail to submit quality
measure data may be subject to a 2
percentage point reduction in their
E:\FR\FM\02SEN1.SGM
02SEN1
]]>Agencies
[Federal Register Volume 76, Number 171 (Friday, September 2, 2011)]
[Notices]
[Pages 54775-54776]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-22501]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Subcommittee on Procedures Review, Advisory Board on Radiation
and Worker Health (ABRWH), National Institute for Occupational Safety
and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting for the
aforementioned subcommittee:
Time and Date: 9 a.m.-5 p.m., September 19, 2011.
Place: Cincinnati Airport Marriott, 2395 Progress Drive, Hebron,
Kentucky 41018, Telephone: (859) 334-4611, Fax: (859) 334-4619.
Status: Open to the public. In the event an individual wishes to
provide comments, written comments must be submitted prior to the
meeting. To access by conference call dial the following information:
(866) 659-0537, Participant Pass Code 9933701.
Background: The ABRWH was established under the Energy Employees
Occupational Illness Compensation Program Act of 2000 to advise the
President on a variety of policy and technical functions required to
implement and effectively manage the compensation program. Key
functions of the ABRWH include providing advice on the development of
probability of causation guidelines that have been promulgated by the
Department of Health and Human Services (HHS) as a final rule; advice
on methods of dose reconstruction which have also been promulgated by
HHS as a final rule; advice on the scientific validity and quality of
dose estimation and reconstruction efforts being performed for purposes
of the compensation program; and advice on petitions to add classes of
workers to the Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the ABRWH to HHS, which subsequently
delegated this authority to CDC. NIOSH implements this responsibility
for CDC. The charter was issued on August 3, 2001, renewed at
appropriate intervals, and will expire on August 3, 2013.
Purpose: The ABRWH is charged with (a) providing advice to the
Secretary, HHS, on the development of guidelines under Executive Order
13179; (b) providing advice to the Secretary, HHS, on the scientific
validity and quality of
[[Page 54776]]
dose reconstruction efforts performed for this program; and (c) upon
request by the Secretary, HHS, advising the Secretary on whether there
is a class of employees at any Department of Energy facility who were
exposed to radiation but for whom it is not feasible to estimate their
radiation dose, and on whether there is a reasonable likelihood that
such radiation doses may have endangered the health of members of this
class. The Subcommittee on Procedures Review was established to aid the
ABRWH in carrying out its duty to advise the Secretary, HHS, on dose
reconstructions. The Subcommittee on Procedures Review is responsible
for overseeing, tracking, and participating in the reviews of all
procedures used in the dose reconstruction process by the NIOSH
Division of Compensation Analysis and Support (DCAS) and its dose
reconstruction contractor.
Matters To Be Discussed: The agenda for the Subcommittee meeting
includes discussion of the following ORAU and OCAS procedures: ORAUT-
RPRT-0044 (``Analysis of Bioassay Data with a Significant Fraction of
Less-Than Results''), OCAS TIB-0013 (``Special External Dose
Reconstruction Considerations for Mallinckrodt Workers''), OTIB-0019
(``Analysis of Coworker Bioassay Data for Internal Dose Assignment''),
OTIB-0021 (External Coworker Dosimetry Data for the X-10 Site), OTIB-
0029 (``Internal Dosimetry Coworker Data for Y-12''), OTIB-0047
(``External Radiation Monitoring at the Y-12 Facility During the 1948-
1949 Period''), OTIB-0049 (``Estimating Doses for Plutonium Strongly
Retained in the Lung''), OTIB-0052 (``Parameters to Consider When
Processing Claims for Construction Trade Workers''), OTIB-0054
(``Fission and Activation Product Assignment for Internal Dose-Related
Gross Beta and Gross Gamma Analyses''), and OTIB-0070 (``Dose
Reconstruction During Residual Radioactivity Periods at Atomic Weapons
Employer Facilities''); and a continuation of the comment-resolution
process for other dose reconstruction procedures under review by the
Subcommittee.
The agenda is subject to change as priorities dictate.
This meeting is open to the public. In the event an individual
wishes to provide comments, written comments must be submitted prior to
the meeting. Any written comments received will be provided at the
meeting and should be submitted to the contact person below in advance
of the meeting.
Contact Person for More Information: Theodore Katz, Executive
Secretary, NIOSH, CDC, 1600 Clifton Road, Mailstop E-20, Atlanta,
Georgia 30333, Telephone: (513) 533-6800, Toll Free: 1 (800) CDC-INFO,
E-mail dcas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention, and the Agency
for Toxic Substances and Disease Registry.
Dated: August 29, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2011-22501 Filed 9-1-11; 8:45 am]
BILLING CODE 4163-18-P
